We are live on ! Find out more
SHG

Sheares Healthcare Group Portfolio holdings

AUM $1.69M
1-Year Est. Return 4.89%
This Fund
S&P 500
This Quarter Est. Return
-13.23%
1 Year Est. Return
-4.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$146M
AUM Growth
–
Cap. Flow
+$161M
Cap. Flow %
110.4%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ONEM
1Life Healthcare
ONEM
+$161M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONEM
1
DELISTED
1Life Healthcare
ONEM
$146M 100%
+8,300,479
New +$161M

Similar funds

IPCP
Iron Park Capital Partners New York $621K AUM 73.14% 1-Year Est. Return
AC
Apogem Capital New York $303K AUM 46.01% 1-Year Est. Return
EC
EMJ Capital Toronto, Ontario, Canada $3.12M AUM 40.6% 1-Year Est. Return
RIR
Rayliant Investment Research Santa Monica, California $6.94M AUM
FWM
Foresight Wealth Management Draper, Utah $6.98M AUM 13.2% 1-Year Est. Return
SKCP
Storm King Capital Partners New York $8.58M AUM 50.59% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return

Sheares Healthcare Group's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Sheares Healthcare Group, which disclosed 1 position worth $146M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is 1Life Healthcare: 8,300,479 shares worth $146M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Sheares Healthcare Group's largest Q4 2021 buy was 1Life Healthcare: 8,300,479 shares worth $146M.
  • Sheares Healthcare Group's ten largest holdings make up 100% of its $146M portfolio in Q4 2021.
  • Sheares Healthcare Group disclosed 1 position in Q4 2021, its first 13F filing on record.

Based on Sheares Healthcare Group's 13F filing for Q4 2021, filed 14 Feb 2022.